health & social care
2

Effectively Preventing and Controlling the Spread of Infections

health & social care

08:45 - 16:00

Thursday 21 March 2019

Congress Centre, Central London

This Forum provides participants with an opportunity to discuss and develop solutions to the latest issues surrounding Infection and Prevention Control (IPC). Attendees will examine the latest guidance and best practice from across the NHS and wider Health Sector on ways to improve patient safety, meet the Government’s 2021 target and reduce antimicrobial resistance.

Audience

This Forum aims to bring together practitioners from across the NHS. Typical job titles include:

  • Lead Nurse – Infection Control
  • Directors of Infection Prevention and Control
  • Matrons
  • Chief Nurses
  • Directors of Nursing
  • Directors of Public Health
  • Directors of Quality
  • Directors of Nursing
  • Directors of Clinical Services

The Forum is also open to the Private Sector to encourage networking and debate.

Key Speakers Confirmed:
  • Joanne Bosanquet, Deputy Chief Nurse, Public Health England 
  • Rose Gallagher MBE, Professional Lead IPC, Royal College of Nursing
  • Professor Jennie Wilson, Vice-President, Infection Prevention Society
View the agenda and additional speakers

Infection prevention and control (IPC) is set to cost the NHS £2.3 billion by 2018. In November 2016, the government announced a national drive to halve the number of Gram-negative bloodstream infections (BSIs) by 2021. In its report, ‘Antimicrobial resistance’, published in October 2018, The Health and Social Care Committee recommended that the government makes tackling antimicrobial resistance a top five policy priority in order to prevent a major step backwards in modern medicine.

New data released by Public Health England (PHE) shows that the number of infections with E. coli, MRSA, and MSSA and Clostridium difficile all increased between 2016 and 2017. Gram-negative BSIs contributed to approximately 5,500 NHS patient deaths in 2015. Sepsis was the leading cause for 15,722 deaths in hospital or within 30 days of patients being discharged in the year ending April 2017.

Preventing BSIs should have a major impact on reducing the need to prescribe antimicrobials, which is a key way of reducing the rise in antibiotic resistance. Addressing E. coli BSIs, which represent 55% of all Gram-negative BSIs and have increased by a fifth in the last five years, has been identified as a priority. A further 18 surgical specialties received an additional £60 million in 2016 via the expansion of the ‘Getting It Right First Time’ programme.

The latest PHE data show a large variation in infection rates across clinical commissioning groups (CCGs). As such, greater cross-service collaboration is needed to reduce the increasing threat of antimicrobial resistance (AMR) and to ensure that all acute providers are successfully lowering the incidences of gram-negative BSIs. This is an issue of national priority, and if the NHS is to meet the Government’s target by 2021, services must work together to share best practice and target resources to areas most in need of improvement.

08:45

Registration, Refreshments and Networking


09:30

Chair's Welcome Address

Professor Heather Loveday, Professor of Evidence based Healthcare and Director of Richard Wells Research Centre, University of West London (CONFIRMED)


09:40

Morning Keynote: Exploring the Future of Infection Prevention and Control Across the NHS

  • Outlining the national picture of IPC and assessing progress on the Government’s ambition to halve Gram-negative BSIs by 2021
  • Discussing the latest guidance for staff on managing cases of infectious diseases in schools and other childcare settings
  • Highlighting the need for greater reporting by trust boards and reflecting on why this is not being done despite being a legislative requirement
  • Targeting improvements in areas such as hydration, treatment of bacterial infection before it becomes a BSI, and reducing unnecessary urinary catheterisation

Joanne Bosanquet, Deputy Chief Nurse, Public Health England (CONFIRMED)


10:10

Special Keynote: Transforming Services Through Cross-Service Collaboration

  • Considering ways to ensure greater cross-service collaboration to address disparities in infection rates across trusts and reduce antimicrobial resistance (AMR)
  • Discussing the challenges facing IPC teams, including staff shortages, limited resources and lack of community engagement
  • Making IPC a priority for all staff and board members, not just dedicated IPC teams, by involving everyone in the target-setting and reporting process
  • Equipping nursing staff with the practical skills needed to manage IPC through the launch of the RCN’s Infection Prevention and Control Module educational programme
  • Detailing the RCN’s current work on raising awareness surrounding effective glove use and the benefits this can bring, including how to recognise dermatitis

Rose Gallagher MBE, Professional Lead for Infection Prevention Control, Royal College of Nursing (CONFIRMED)


10:40

Questions and Answers Session


11:00

Refreshments and Networking


11:20

Case Study: Effectively Supporting Workforce Development to Improve Infection Prevention

  • Outlining HIS’s Directors of Infection Prevention and Control Network and Development programme, which aims to improve infection prevention through knowledge sharing and networking opportunities
  • Highlighting how the Healthcare Infection Society (HIS) supports workforce development in tackling infections through online educational resources
  • HIS research, public engagement, supported events and career development grants
  • Analysing the importance of effectively educating healthcare staff in stopping the spread of infections, which has seen HIS establish Foundation Certificates in Infection Prevention and Control to further support workforce development

Kay Miller, Chief Executive, Healthcare Infection Society (CONFIRMED)


11:40

Case Study: Implementing a Continuous Improvement Programme in IPC Reduction

  • Discussing the importance of a Continuous Improvement Programme in the effective reduction of GNBSIs across the Trust, and detailing the process of establishing one
  • Improving IPC across the Trust by focusing on early identification, treatment within the “golden hour” and definitive management of patients with BSIs
  • Raising awareness across the Trust and giving confidence to staff to identify potential BSIs and escalating to suitable colleagues
  • Assessing the impact on patients of the ‘Lean for Leaders’ development programme in helping teams adopt a wide range of effective tools and techniques

CHKS Top 40 Hospitals Awards winners 2018

Ashley Flores, Nurse Consultant and Deputy Director IPC, Surrey and Sussex Healthcare NHS Trust (CONFIRMED)


12:00

Questions and Answers Session


12:20

Lunch and Networking


13:20

Afternoon Keynote: Enhancing IPC Workforce Standards

  • Examining the IPS’s professional competences, providing leaders with a framework to effectively assess the professional development of their infection prevention staff
  • Discussing the development of the UK’s first specialist infection prevention credentialing system to help employers to recruit, maintain and develop an IPC service that is led by a highly-skilled, capable workforce
  • Outlining the key points from the IPS Strategic Plan 2017-2020 and how it aligns with and seeks to facilitate the Government’s 2021 ambitions for halving GNBSIs
  • Considering surveillance as an important way to provide quality outcome indicators and identify key measures in order to reduce the burden of hospital-acquired infections

Professor Jennie Wilson, Vice-President, Infection Prevention Society (IPS) (CONFIRMED)


13:50

Case Study: Creating Manageable Goals and Encouraging Staff Engagement to Reduce Gram-negative BSIs

  • Outlining the challenges encountered in designing a project to work towards reducing Gram-negative bloodstream infections by 50% by 2021
  • Examining the outcomes from the programme that has been running for a year, namely a 35% reduction in the number of hospital-acquired E coli BSIs
  • Combining projects to create focused and manageable principles for staff to use in their clinical environment and generate a higher level of staff engagement
  • Charting the Trust’s work over the last two years, from a focus on CAUTI in 2016 to greater engagement with staff and domestics in 2017, to a current drive to achieve patient and public involvement
  • Establishing a culture of continuous improvement, and acknowledging how health inequalities must be considered in creating manageable goals

Julie Clarke, Acting Lead IPC Team, Burton Hospitals NHS Foundation Trust (CONFIRMED)

Jayne Bateman, Acting Deputy for Infection Prevention and Control, Burton Hospitals NHS Foundation Trust (CONFIRMED)


14:10

Questions and Answers Session


14:30

Refreshments and Networking


14:50

Case Study: The importance of Digital and Mobile Strategies in Infection Prevention and Control

  • Considering the importance of implementing digital mobile strategies in the effective prevention and control of infection at the Trust
  • Introducing an IPC model for clinical practice at Dorset County Hospital and evaluating its effectiveness and how other Trusts can adopt a similar model
  • Demonstrating tools used to monitor and detect outbreaks or potential outbreaks and evaluating their effectiveness
  • Discussing techniques to gain greater Board engagement in outbreak management, and monitoring staff engagement and compliance with policy and target-setting

Emma Hoyle, Associate Director for Infection Prevention & Control, Dorset County Hospital NHS Foundation Trust (CONFIRMED)


15:10

Case Study: Reducing Unwarranted Variation in IPC Through the Getting It Right First Time Programme

  • Discussing the Getting It Right First Time (GIRFT) initiative aimed at reducing unwarranted variation in care with regards to infection prevention and control
  • Providing recommendations for trusts based on performance data
  • Outlining the results from the 2017 audit of patients with surgical site infections (SSIs)
  • Considering trusts’ role in collecting this data, and making this compulsory to ensure that trusts and surgeons are aware of the infection rates for their speciality
  • Commenting on the suggestions from the GIRFT programme and how they aim to involve clinicians to deliver continuous quality improvement

Cherrie Ho, National Medical Director’s Clinical Fellow and Joint Clinical Lead, Surgical Site Infection Audit, Getting It Right First Time (CONFIRMED)


15:40

Questions and Answers Session


16:00

Chair's Summary and Close

*programme subject to change


You May Also Like

  • National Nursing Conference 2019

    27 February 201908:45 - 16:00

    Central London

    VIEW AGENDA